Clinical Trials on Vasopressor Agents in China

Total 72 results

The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients

Kidney Transplantation | Immunosuppressive Agents

China
Ruijin Hospital

Completed

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery (DACAB)

Coronary Artery Bypass | Antiplatelet Agents

China
RenJi Hospital
BeiGene; Huidu Shanghai Medical Sciences Ltd

Recruiting

Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) (TACBIN-01)

Urologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, Immunological

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.

Myeloid Malignancy | Venetoclax | Hypomethylating Agent

China
Third Military Medical University

Recruiting

Risk of NSAIDs on Anastomotic Leak for Rectal Surgery

Anastomotic Leak | Anti-Inflammatory Agents, Non-Steroidal

China
Peng Yuan

Completed

Anlotinib in Metastatic HER2 Negative Breast Cancer

Breast Neoplasm | Antineoplastic Agents | Anlotinib

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI. (PACER-PJI)

Periprosthetic Joint Infection | Anti-Bacterial Agents

China
First Affiliated Hospital, Sun Yat-Sen University

Completed

Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy.

Pain, Postoperative | Laparoscopy | Anti-Inflammatory Agents, Non-Steroidal

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma (GALAXY-1)

Neoplasms | Antineoplastic Agents | Carcinoma, Squamous

China
Sichuan Provincial People's Hospital

Recruiting

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children

Perioperative Respiratory Adverse Events

China
Children's Hospital of Fudan University

Recruiting

Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy

Cholangitis | Anti-Bacterial Agents | Biliary Atresia

China
Xiang Guang-da

Completed

The Effect of Contrast Agent on Endothelial Function in Healthy Men

Cytokines | Endothelial Function | Contrast Agent | Apoptosis of Endothelial Progenitor Cell | Free Radical | Alpha-lipoic Acid

China
Guohui Li

Recruiting

Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients

PD-1 | Immune Related Adverse Events

China
The University of Hong Kong

Terminated

Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents

Gastric Ulcer Induced by Anti-platelet Agent | Duodenal Ulcer Induced by Anti-platelet Agent | OGD

China, Hong Kong
Lei Du

Unknown

The Perioperative Risks of Adverse Events After Cardiac Surgery: a Retrospective Study (PRAECS)

Risks of Adverse Events After Cardiac Surgery

China
Affiliated Hospital to Academy of Military Medical...

Recruiting

Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome (eDC-MDS)

Myelodysplastic Syndromes | Immunotherapy | Dendritic Cell | Hypomethylating Agents

China
Qilu Hospital of Shandong University

Unknown

Relationship Between ALDH2 and CIN (REACTION)

Radiographic Contrast Agent Nephropathy

China
Tianjin Medical University Second Hospital

Not yet recruiting

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Urogenital Neoplasms | Urothelial Carcinoma | Antineoplastic Agents | Gemcitabine | Cisplatin | Anlotinib | Carboplatin

China
Lin Zhao

Recruiting

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

In-stent Restenosis | Major Adverse Cardiovascular Events

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
CCRF Consulting Co., Ltd.
Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.

Unknown

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

Free Rate of Cardiac or Cerebrovascular Events | Transradial-transfemoral Coronary Interventions Comparison

China
Shanghai 10th People's Hospital

Unknown

Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population (SAFAR-China)

Blood Pressure | Cardiovascular Risk Factor | Overall Mortality | Cardiovascular Mortality | Cardiovascular Events | Target Organ Damage

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Tianjin Chest Hospital

Unknown

Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.

Percutaneous Coronary Intervention | Saphenous Vein Graft Disease | Major Adverse Cardiovascular Events | Virtual Histology Intravascular Ultrasound

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Huashan Hospital; The Second Affiliated Hospital of Harbin Medical University; Meng Chao Hepatobiliary Hospital of Fujian Medical University

Not yet recruiting

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Carcinoma | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Antineoplastic Agents | Oxaliplatin | Donafenib | Fluorouracil | Antimetabolites

China
Huashan Hospital

Enrolling by invitation

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients (ABNCM)

Antifungal Agents | Cryptococcal Meningitis

China
Nanfang Hospital of Southern Medical University

Unknown

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation

China
Shanglong Yao

Withdrawn

Anesthesia Quality Control Indicators of 6 Provinces in Central China

Anesthesia-related Quality Control Indicators | Anesthesia-related Adverse Events

China
China National Center for Cardiovascular Diseases
China International Medical Foundation

Recruiting

The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement

Heart Failure | Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Cardiac Event | Safety Issues | Effect of Drug | Inotropic Agents

China
Shanghai Zhongshan Hospital
Wu Jieping Medical Foundation

Unknown

A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

Ankylosing Spondylitis | Therapeutic Agent Toxicity

China
Sichuan Cancer Hospital and Research Institute

Recruiting

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Liver Diseases | Digestive System Neoplasms | Liver Neoplasms | Hepatocellular Carcinoma | Antineoplastic Agents | Molecular Mechanisms of Pharmacological Action | Protein Kinase Inhibitors | Sorafenib

China
Air Force Military Medical University, China

Unknown

Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China

To Assess the Long-term Risk for Adverse Events After PE.

China
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Zhong Wang
Shanxi Zhendong Pharmacy Co., Ltd

Recruiting

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Jinling Hospital, China

Recruiting

Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC

Neoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital Diseases

China
Ruijin Hospital

Withdrawn

Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft (DACAB-GI-2)

Gastric Ulcer Induced by Antiplatelet Agent | Ulcer of the Gastrointestinal Tract | Proton Pump Inhibitor

China
First Affiliated Hospital of Chongqing Medical...

Completed

Impact and Mechanism of Depression on Cardio-cerebral Vascular Events and Arteriovenous Fistula Dysfunction in MHD Patients

Cardio-cerebral Vascular Events | Arteriovenous Fistula Dysfunction

China
Qilu Hospital of Shandong University

Unknown

2019-nCoV Outbreak and Cardiovascular Diseases

Cardiovascular Death; Major Adverse Cardiovascular Events

China
Zhong Wang
Shanxi Zhendong pharmaceutical Co. LTD.

Completed

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Xijing Hospital

Unknown

Monitoring of Cerebral and Abdominal Tissue Oxygen Saturation in Neonates

Establish the Incidence Rate of Abdominal and Cerebral Hyperoxemia and Hypoxemia Events in Neonates at Birth

China
Beijing Tsinghua Chang Gung Hospital

Recruiting

Construction of a Prediction Model for MACCE in Elderly Patients After Elective Non-cardiac Surgery

Postoperative Complications | Cerebrovascular Accident | Major Adverse Cardiac Events | Models

China
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

Blood Pressure | Renal Artery Obstruction | Glomerular Filtration Rate | Stents | Lipids

China
Beijing Tiantan Hospital

Recruiting

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR)

Unruptured Intracranial Aneurysm | Thromboembolic Events | Flow Diverter | Stent-assisted Coiling

China
Qilu Hospital of Shandong University

Completed

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease

China
Chinese PLA General Hospital
Peking University First Hospital; Xiangya Hospital of Central South University and other collaborators

Recruiting

Perioperative Database of Chinese Elderly Patients (PDCEP)

Perioperative/Postoperative Complications | Perioperative Adverse Events | Perioperative Complications

China
Beijing Anzhen Hospital

Enrolling by invitation

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Drug-Eluting Stents

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Lung Cancer

MRI | Genes | Response | Lung Cancer Squamous Cell | CT

China
Xiaoxiang Chen

Unknown

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (AVANIRA3)

Neoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditions

China
Xiaoxiang Chen

Recruiting

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (ANLOLA)

Neoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditions

China
Nanjing First Hospital, Nanjing Medical University
National Natural Science Foundation of China; Nanjing Medical University

Recruiting

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI (SHAWN)

Hyperlipidemias | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Cardiovascular Events

China

Clinical Trials on Vasopressor Agents in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations